Exact Mass: 676.3771

Exact Mass Matches: 676.3771

Found 40 metabolites which its exact mass value is equals to given mass value 676.3771, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Actein

[2-Hydroxy-1,4,6,12,17,17-hexamethyl-18-(3,4,5-trihydroxyoxan-2-yl)oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O11 (676.3822)


   

Cimiracemoside G

Cimiracemoside G

C37H56O11 (676.3822)


   
   

Actaeaepoxide 3-O-beta-D-xylopyranoside

Actaeaepoxide 3-O-beta-D-xylopyranoside

C37H56O11 (676.3822)


   

Actein

[(1S,1R,2S,3R,4R,4R,5R,5R,6R,10S,12S,13S,16R,18S,21R)-2-hydroxy-1,4,6,12,17,17-hexamethyl-18-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O11 (676.3822)


Actein is a triterpenoid. It has a role as a metabolite. Actein is a natural product found in Actaea elata, Actaea cimicifuga, and other organisms with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa.

   

(23R,24R)-16beta,23;16alpha,24-diepoxy-12beta-acetoxy-cycloart-7-en-3beta,15alpha,25-triol 3-O-beta-D-xylopyranoside

(23R,24R)-16beta,23;16alpha,24-diepoxy-12beta-acetoxy-cycloart-7-en-3beta,15alpha,25-triol 3-O-beta-D-xylopyranoside

C37H56O11 (676.3822)


   

3beta-O-(beta-D-glucuronopyranosyl)-olean-12-ene-28,29-dioic acid 29-methyl ester|coryternic acid 3-O-beta-D-glucuronopyranoside

3beta-O-(beta-D-glucuronopyranosyl)-olean-12-ene-28,29-dioic acid 29-methyl ester|coryternic acid 3-O-beta-D-glucuronopyranoside

C37H56O11 (676.3822)


   

27-Deoxyactein

27-Deoxyactein

C37H56O11 (676.3822)


   

Granadaene

(2S)-5-amino-2-(27R-O-alpha-L-rhamnopyranosyl-2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E-octacosadodecaenoyl)pentanoic acid

C39H52N2O8 (676.3723)


   

Rapacuronium Bromide

Rapacuronium Bromide

C37H61BrN2O4 (676.3814)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Rapacuronium bromide (Org 9487), a non-depolarizing neuromuscular blocker, is an allosteric modulator of muscarinic acetylcholine receptor (mAChR)[1].

   

Cimiracemoside A

Cimiracemoside A

C37H56O11 (676.3822)


   

(5R)-3-O-[(2E)-3-carboxyprop-2-enoyl]-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4R,6R,9S,10S,11R,12R,14R)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4,5-dimethyl-beta-L-erythro-pentopyranose

(5R)-3-O-[(2E)-3-carboxyprop-2-enoyl]-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4R,6R,9S,10S,11R,12R,14R)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4,5-dimethyl-beta-L-erythro-pentopyranose

C37H56O11 (676.3822)


   

N-[5-[3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

N-[5-[3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]propanoylamino]pentyl]-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanamide

C37H52N6O4S (676.3771)


   

Hygrolidin

Hygrolidin

C37H56O11 (676.3822)


A macrolide consisting resulting from the formal lactonisation of the carboxy group of (2E,4E,6R,7S,8S,10E,12E,14S,15R,16S,17R,18S)-18-[(2R,4R,5S,6R)-4-{[(2E)-3-carboxyprop-2-enoyl]oxy}-2-hydroxy-5,6-dimethyltetrahydro-2H-pyran-2-yl]-7,15,17-trihydroxy-14-methoxy-2,4,6,8,10,16-hexamethylnonadeca-2,4,10,12-tetraenoic acid with the hydroxy group at position 15. It is active against SV40 tumour cells, and inhibits the growth of solid tumour-derived cell lines such as DLD-1 human colon cancer cells with increased cells in G1 and S phases.

   

Cimiracemoside F

Cimiracemoside F

C37H56O11 (676.3822)


A natural product found in Actaea racemosa.

   
   
   

PA 22:5/12:3;O

PA 22:5/12:3;O

C37H57O9P (676.374)


   
   
   

PEth 32:8;O

PEth 32:8;O

C37H57O9P (676.374)


   
   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

acetylacetol 3-o-arabinoside

NA

C37H56O11 (676.3822)


{"Ingredient_id": "HBIN014443","Ingredient_name": "acetylacetol 3-o-arabinoside","Alias": "NA","Ingredient_formula": "C37H56O11","Ingredient_Smile": "NA","Ingredient_weight": "676.843","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7225","PubChem_id": "NA","DrugBank_id": "NA"}

   

21,22-dihydroxy-1,6,6,15,17,20,20-heptamethyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacos-2-en-14-yl acetate

21,22-dihydroxy-1,6,6,15,17,20,20-heptamethyl-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-19,23-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹⁰.0¹⁰,¹².0¹⁶,²⁴.0¹⁸,²²]pentacos-2-en-14-yl acetate

C37H56O11 (676.3822)


   

7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   
   

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1s)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

(1s,3r,3's,4r,5r,6s,7r,8r,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

(1s,3r,3's,4r,5r,6s,7r,8r,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3s,4r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

5-amino-2-({1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene}amino)pentanoic acid

5-amino-2-({1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene}amino)pentanoic acid

C39H52N2O8 (676.3723)


   

(1s,3r,3's,4r,5r,6s,7r,8s,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

(1s,3r,3's,4r,5r,6s,7r,8s,10s,12s,16r,18s,21r)-7-hydroxy-3'-(2-hydroxypropan-2-yl)-4,6,12,17,17-pentamethyl-18-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-9-oxaspiro[hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,2'-oxiran]-13-en-3-yl acetate

C37H56O11 (676.3822)


   

(1r,1'r,2r,3'r,4s,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1r,1'r,2r,3'r,4s,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1r)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-9-[(1r)-1-hydroxyethyl]-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

(1'r,2r,4'r,5s,5'r,10's,12's,13's,16'r,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1'r,2r,4'r,5s,5'r,10's,12's,13's,16'r,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

15-benzyl-8,11,17-trihydroxy-9-(1-hydroxyethyl)-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

15-benzyl-8,11,17-trihydroxy-9-(1-hydroxyethyl)-6-(hydroxymethyl)-3-isopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C34H52N4O10 (676.3683)


   

5-amino-2-{[(2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene]amino}pentanoic acid

5-amino-2-{[(2e,4e,6e,8e,10e,12e,14e,16e,18e,20e,22e,24e)-1-hydroxy-27-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]octacosa-2,4,6,8,10,12,14,16,18,20,22,24-dodecaen-1-ylidene]amino}pentanoic acid

C39H52N2O8 (676.3723)


   

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

(1s,1'r,2r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)


   

4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H56O11 (676.3822)